WATSON 347 12.5 mg (Hydrochlorothiazide 12.5 mg)
Pill imprint WATSON 347 12.5 mg has been identified as Hydrochlorothiazide 12.5 mg.
Hydrochlorothiazide is used in the treatment of high blood pressure; edema; nephrocalcinosis; diabetes insipidus; osteoporosis and belongs to the drug class thiazide diuretics. There is no proven risk in humans during pregnancy. Hydrochlorothiazide 12.5 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 12.5 mg
- Turquoise & White
- 14.00 mm
- Prescription only
D&C Red No. 28
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
|NDC Code||Manufacturer / Repackager|
|54569-5236||A-S Medication Solutions, LLC (repackager)|
|67544-1009||Prepak Systems Inc (repackager)|
|23490-7038||Palmetto State Pharmaceuticals Inc (repackager)|
|57866-6733||Direct Dispensing Inc (repackager)|
|16590-0580||Stat RX USA LLC (repackager)|
|49999-0388||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about hydrochlorothiazide
- Hydrochlorothiazide capsules
- Hydrochlorothiazide solution
- Hydrochlorothiazide (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.